PP
Propanc Biopharma, Inc.
PPCB · NASDAQ
$0.61 -7.99% (-$0.05)
1M -47.41%
Market Cap $1.44M
P/E Ratio -
Div. Yield -
ROE 148.23%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.15x
EV/EBITDA N/A
P/S N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 148.23%
ROA 128.10%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 2.37x
Int. coverage -26.93x
Debt/Equity 0.16x
Stability
44 /100
Moderate EPS volatility 1.31%
Profitable years 0
Beta 3.33x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre PPCB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James Nathanielsz
Employees
2
Headquarters
Camberwell